C12Y 301/01053
Sialate o-acetylesterase
Official title: Sialate O-acetylesterase (3.1.1.53)
C12Y301/01053 (Sialate o-acetylesterase) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 8
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified mammalian cells24 Sep 2024US 12,098,365 B2Genentech, Inc.
- Development of a preventive influenza D virus vaccine30 Mar 2021US 10,960,069 B2NUtech Ventures
- Bifidobacterial gene sequences and their use7 Apr 2015US 8,999,705 B2The Regents of the University of California
- Bifidobacterial gene sequences and their use29 Jan 2013US 8,361,756 B2The Regents of the University of California
- Modified mammalian cells9 Apr 2026US 2026/0098254 A1Genentech, Inc.
- Modified mammalian cells27 Mar 2025US 2025/0101411 A1Genentech, Inc.
- Serine hydrolase profiling assay in biotherapeutics20 Jan 2022US 2022/0018849 A1
- Modified mammalian cells7 Oct 2021US 2021/0309989 A1Genentech, Inc.
- Methods and compositions comprising reduced level of host cell proteins14 Jan 2021US 2021/0008199 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents